bioAffinity Technologies Inc — Cash Flow (NASDAQ:BIAF) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics

Quarterly Annual

Cash from operating activities -4.07 M-6.04 M-7.26 M -8.45 M Cash from investing activities -219.99 K-2.21 M-79.08 K -60.57 K Cash from financing activities 14.34 M-344.98 K5.63 M 15.42 M Free cash flow -4.29 M-6.06 M-7.34 M -8.51 M

Notizie

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.25%

bioAffinity Technologies pubblica i risultati finanziari 2025

bioAffinity Technologies reports 2025 financial results

bioAffinity Technologies Stock Soars 120% On CyPath Lung Sales Growth - bioAffinity Technologies (NASDAQ:BIAF)

BIAF vs. GH: Which Cancer Detection Stock Is the Better Buy Now?

bioAffinity presenta ricerca su terapie per l’asma all’AAAAI

bioAffinity presents asthma therapy matching research at AAAAI

bioAffinity avvia studio per testare diagnostica del cancro ai polmoni

bioAffinity launches study to test lung cancer diagnostic

Il test CyPath Lung evita una biopsia non necessaria in una paziente anziana

CyPath Lung test helps avoid unnecessary biopsy in elderly patient

bioAffinity Technologies amplia il consiglio consultivo medico con esperti polmonari